ClinicalTrials.Veeva

Menu

The Use of Low Molecular Weight Heparin in Hemodiafiltration

G

Ghent University Hospital (UZ)

Status and phase

Completed
Phase 4

Conditions

Chronic Kidney Disease

Treatments

Procedure: 5 minutes after the start of the session, at the inlet line
Procedure: At start of the session, at the inlet line
Procedure: At the start of the session, at the outlet line

Study type

Interventional

Funder types

Other

Identifiers

NCT00756145
2008/421

Details and patient eligibility

About

Low molecular weight heparin (LMWH) is injected in the dialysis circuit at the start of the session. In the present study we compare 3 different methods of injection of LMWH: parameters of dialysis efficiency and clotting are measured. The study lasts 3 sessions for each patient.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic kidney disease stade V treated with hemodiafiltration
  • age >18 year
  • Hematocrit > 30%

Exclusion criteria

  • treatment with vitamin K antagonists
  • treatment with other anti-coagulants or heparin besides the heparin used during dialysis
  • active bleeding, infection or malignancy
  • heparin associated allergy
  • hepatic failure
  • trombocytopenia < 120.000/µl

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

15 participants in 3 patient groups

1
Experimental group
Description:
Injection of LMWH at the start of the hemodiafiltration session, at the inlet bloodline
Treatment:
Procedure: At start of the session, at the inlet line
2
Experimental group
Description:
Injection of LMWH 5 minutes after the start of the hemodiafiltration session, at the inlet bloodline
Treatment:
Procedure: 5 minutes after the start of the session, at the inlet line
3
Experimental group
Description:
Injection of LMWH at the start of the hemodiafiltration session, at the outline bloodline
Treatment:
Procedure: At the start of the session, at the outlet line

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems